[Hepatitis B markers in children with oncological diseases].
High-sensitivity methods were employed to test blood serum for hepatitis B markers in 293 infant cancer patients. HBsAg was identified in 31.7 while anti-HBs--in 16.7% of cases. Hepatitis B markers most frequently occurred in patients suffering from lymphoproliferative diseases (60.1%). HBeAg was detected in 46.5% of patients with HBsAg. The results point to a high incidence of hepatitis B virus in cancer patients.
D002648:Child; D006509:Hepatitis B / Q000175:diagnosis*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006513:Hepatitis B e Antigens / Q000032:analysis; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000150:complications / Q000276:immunology; D009369:Neoplasms / Q000150:complications* / Q000276:immunology; D012698:Serologic Tests / Q000379:methods
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens
Markery gepatitia B u deteĭ pri onkologicheskikh zabolevaniiakh.